Integrating UPLC-HR-MS, network pharmacology and experimental validation to reveal the potential mechanism of Fuzheng Bixie granules in treating acute lung injury
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-025-04590-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Luyin Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Traditional Chinese Medicine Clinical Research Base and Drug Research Center of Integrated Traditional Chinese and Western Medicine, the Aff…. Hauptthemen laut MEDLINE: Acute Lung Injury, Drugs, Chinese Herbal, Anti-Inflammatory Agents. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine, Traditional Chinese Medicine Science and Technology Industry Innovation Tteam of Sichuan Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Acute lung injury (ALI) is a severe pulmonary complication. Fuzheng Bixie Granules (FZBXG) is a traditional Chinese medicine formula with significant antipyretic, anti-inflammatory, analgesic, and microcirculation-improving effects. In clinical practice, it is used to treat patients with pneumonia and lung injury caused by viral infections, demonstrating favorable efficacy, and its clinical value has been preliminarily validated. However, a deeper understanding of its anti-lung injury mechanisms and the identification of its core active components will contribute to a more comprehensive insight into the potential applications of FZBXG in the treatment of ALI. In this study, the bioactive components of FZBXG was firstly analyzed by UPLC-HR-MS technology. Network pharmacology was utilized to identify related targets and potential pathways of FZBXG in the treatment of ALI. Additionally, LPS-stimulated Raw264.7 inflammatory cell models and ALI mouse models were established for validation. Eventually, a total of 189 chemical components were identified, mainly flavonoids, terpenes and glycosides. Network pharmacology analysis revealed that FZBXG is involved in the treatment of ALI through the IL-17 signaling pathway, NF-κB signaling pathway, and TNF signaling pathway. Animal experiments showed that FZBXG treatment significantly alleviated lung pathology, attenuate inflammatory responses in mice with ALI. FZBXG reduced the expression of phosphorylated AKT, p38 MAPK, and NF-κB while upregulated Nrf2/HO-1 signaling. Through the analysis of the active components of FZBXG and its mechanisms against acute lung injury, a theoretical basis is provided for the clinical promotion of FZBXG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Traditional Chinese Medicine Clinical Research Base and Drug Research Center of Integrated Traditional Chinese and Western Medicine, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical Unive…
- Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, 646000, China.
- Core Facility, West China Hospital, Sichuan University, Chengdu, 610000, China.
- The Czech Center for Traditional Chinese Medicine, Jeremenkova 1211/40, Olomouc, 77900, Czech Republic.
- Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, 646000, China. renwei1991@swmu.edu.cn.
- Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, 646000, China. xuhoupingphd@163.com.
Förderung
- Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine
- Traditional Chinese Medicine Science and Technology Industry Innovation Tteam of Sichuan Administration of Traditional Chinese Medicine
Zitieren
APA
Yang, L., Wu, Z., Li, Y., Ren, G., Spáčil, R., Ren, W., & Xu, H. (2026). Integrating UPLC-HR-MS, network pharmacology and experimental validation to reveal the potential mechanism of Fuzheng Bixie granules in treating acute lung injury. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04590-1
Vancouver
Yang L, Wu Z, Li Y, Ren G, Spáčil R, Ren W, et al. Integrating UPLC-HR-MS, network pharmacology and experimental validation to reveal the potential mechanism of Fuzheng Bixie granules in treating acute lung injury. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04590-1
BibTeX
@article{Yang2026,
author = {Yang, Luyin and Wu, Zhihao and Li, Yinyin and Ren, Guilin and Spáčil, Roman and Ren, Wei and Xu, Houping},
title = {Integrating UPLC-HR-MS, network pharmacology and experimental validation to reveal the potential mechanism of Fuzheng Bixie granules in treating acute lung injury},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-025-04590-1}
}
EUVIMED